VIVUS Press Releases

Date Title Links
Toggle Summary VIVUS Announces Date of 2016 Fourth Quarter Business Update and Financial Results Teleconference
CAMPBELL, CA -- (Marketwired) -- 02/28/17 -- VIVUS, Inc. (NASDAQ: VVUS) today announced that it will report financial results and provide a business update for the fourth quarter of 2016 after the NASDAQ Market closes on Wednesday, March 8, 2017 . The company will conduct a conference call and an
Toggle Summary VIVUS and Selten Pharma Announce Agreement for the Development and Commercialization Rights to Treatments for Pulmonary Arterial Hypertension (PAH)
CAMPBELL, CA , and SAN CARLOS, CA -- (Marketwired) -- 01/09/17 -- VIVUS, Inc. ( NASDAQ : VVUS) and Selten Pharma, Inc. , announced VIVUS' acquisition from Selten of exclusive, worldwide rights for the development and commercialization of tacrolimus and ascomycin for the treatment of Pulmonary